Severe rebound disease activity after fingolimod withdrawal in a pregnant woman with multiple sclerosis managed with rituximab: A case study

• Main Authors: Beatriz Canibaño (Author), Musab Ali (Author), Boulenouar Mesraoua (Author), Gayane Melikyan (Author), Hasan Al Hail (Author), Faiza Ibrahim (Author), Yolande Hanssens (Author), Dirk Deleu (Author)
• Format: Book
• Published: Elsevier, 2020-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Although pregnancy is potentially protective against relapses of multiple sclerosis, severe rebound of disease activity after withdrawal of fingolimod may occur. We report a woman with multiple sclerosis who discontinued fingolimod in the first month of her pregnancy. She developed severe disease re...